Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 37, 2023 - Issue 18
400
Views
2
CrossRef citations to date
0
Altmetric
Short Communication

Naringenin biosynthesis and fabrication of naringenin mediated nano silver conjugate for antimicrobial potential

ORCID Icon, ORCID Icon & ORCID Icon
Pages 3184-3190 | Received 27 Jun 2022, Accepted 07 Nov 2022, Published online: 22 Nov 2022

References

  • Alam MA, Subhan N, Rahman MM, Uddin SJ, Reza HM, Sarker SD. 2014. Effect of citrus flavonoids, naringin and naringenin, on metabolic syndrome and their mechanisms of action. Adv Nutr. 5(4):404–417.
  • Anandalakshmi K, Venugobal J, Ramasamy V. 2016. Characterization of silver nanoparticles by green synthesis method using Pedalium murex leaf extract and their antibacterial activity. Appl Nanosci. 6(3):399–408.
  • Aqeel Y, Siddiqui R, Anwar A, Shah MR, Khan NA. 2016. Gold nanoparticle conjugation enhances the antiacanthamoebic effects of chlorhexidine. Antimicrob Agents Chemother. 60(3):1283–1288.
  • Borase HP, Patil CD, Sauter IP, Rott MB, Patil SV. 2013. Amoebicidal activity of phytosynthesized silver nanoparticles and their in vitro cytotoxicity to human cells. FEMS Microbiol Lett. 345(2):127–131.
  • Brahmkhatri VP, Chandra K, Dubey A, Atreya HS. 2015. An ultrastable conjugate of silver nanoprticles and protein formed through weak interactions. Nanoscale. 7(30):12921–12931.
  • Cavia-Saiz M, Busto MD, Pilar-Izquierdo MC, Ortega N, Perez-Mateos M, Muñiz P. 2010. Antioxidant properties, radical scavenging activity and biomolecule protection capacity of flavonoid naringenin and its glycoside naringin: a comparative study. J Sci Food Agric. 90(7):1238–1244.
  • Celiz G, Daz M, Audisio MC. 2011. Antibacterial activity of naringin derivatives against pathogenic strains. J Appl Microbiol. 111(3):731–738.
  • Chowdhuri AR, Tripathy S, Haldar C, Chandra S, Das B, Roy S, Sahu SK. 2015. Theoretical and experimental study of folic acid conjugated silver nanoparticles through electrostatic interaction for enhance antibacterial activity. RSC Adv. 5(28):21515–21524.
  • Farajtabar A, Ghari F. 2013. Spectral analysis of naringenin deprotonation in aqueous ethanol solutions. Chem Pap. 67:538–545.
  • Funiss BS, Hannaford AJ, Smith EWG, Tatchell AR. 1989. Vogel’s Textbook of practical organic chemistry. 5th Ed. Longman Scientific and Technical. New York. 171:175 ISBN 0-582-46-236-3
  • Gakiya-Teruya M, Palomino-Marcelo L, Pierce S, Angeles-Boza AM, Krishna V, Rodriguez-Reyes JCF. 2020. Enhanced antimicrobial activity of silver nanoparticles conjugated with synthetic peptide by click chemistry. J Nanopart Res. 22(4):1–11.
  • Habelt K, Pittner F. 1983. A rapid method for the determination of naringin, prunin, and naringenin applied to the assay of naringinase. Anal Biochem. 134(2):393–397.
  • Halawani EM, Hassan AM, El-Rab SMG. 2020. Nanoformulation of biogenic cefotaxime-conjugated-silver nanoparticles for enhanced antibacterial efficacy against multidrug-resistant bacteria and anticancer studies. Int J Nanomedicine. 15:1889–1901.
  • Harborne JB, Williams CA. 2000. Advances in flavonoid research since. Phytochemistry 55(6):481–504.
  • Hendiger EB, Padzik M, Żochowska A, Baltaza W, Olędzka G, Zyskowska D, Bluszcz J, Jarzynka S, Chomicz L, Grodzik M, et al. 2020. Tannic acid-modified silver nanoparticles enhance the anti-Acanthamoeba activity of three multipurpose contact lens solutions without increasing their cytotoxicity. Parasites Vectors. 13(1):1–8.
  • Hernández-Aquino E, Muriel P. 2018. Beneficial effects of naringenin in liver diseases: molecular mechanisms. World J Gastroenterol. 24(16):1679–1707.
  • Ji P, Yu T, Liu Y, Jiang J, Xu J, Zhao Y, Hao Y, Qiu Y, Zhao W, Wu C. 2016. Naringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics. Drug Des Devel Ther. 10:911–925.
  • Kishi K. 1955. Production of naringinase from Aspergillus niger Kagaku to Kogyo. Chem Ind J. 29:140.
  • Kumar RP, Abraham A. 2016. PVP-coated naringenin nanoparticles for biomedical applications–In vivo toxicological evaluations. Chem Biol Interact. 257:110–118.
  • Masri A, Anwar A, Ahmed D, Siddiqui RB, Raza Shah M, Khan NA. 2018. Silver nanoparticle conjugation-enhanced antibacterial efficacy of clinically approved drugs cephradine and vildagliptin. Antibiotics 7(4):100.
  • Muniyan A, Ravi K, Mohan U, Panchamoorthy R. 2017. Characterization and in vitro antibacterial activity of saponin-conjugated silver nanoparticles against bacteria that cause burn wound infection. World J Microbiol Biotechnol. 33(7):1–12.
  • Ng’uni T, Mothlalamme T, Daniels R, Klaasen J, Fielding BC. 2015. Additive antibacterial activity of naringenin and antibiotic combinations against multidrug resistant Staphylococcus aureus. Afr J Microbiol Res. 9:1513–1518.
  • Niyyati M, Sasani R, Mohebali M, Ghazikhansari M, Kargar F, Hajialilo E, Rezaeian M. 2018. Anti-Acanthamoeba effects of silver and gold nanoparticles and contact lenses disinfection solutions. Iran. J Parasitol. 13(2):180.
  • Padzik M, Hendiger EB, Chomicz L, Grodzik M, Szmidt M, Grobelny J, Lorenzo-Morales J. 2018. Tannic acid-modified silver nanoparticles as a novel therapeutic agent against Acanthamoeba. Parasitol Res. 117(11):3519–3525.
  • Pereira R, Andrades NE, Paulino N, Sawaya AC, Eberlin MN, Marcucci MC, Favero GM, Novak EM, Bydlowski SP. 2007. Synthesis and characterization of a metal complex containing naringin and Cu, and its antioxidant, antimicrobial, antiinflammatory and tumor cell cytotoxicity. Molecules 12(7):1352–1366.
  • Puri M, Banerjee UC. 2000. Production, purification, and characterization of the debittering enzyme naringinase. Biotechnol Adv. 18(3):207–217.
  • Ravi SS, Christena LR, SaiSubramanian N, Anthony SP. 2013. Green synthesized silver nanoparticles for selective colorimetric sensing of Hg2+ in aqueous solution at wide pH range. Analyst. 138(15):4370–4377.
  • Salehi B, Fokou P, Sharifi-Rad M, Zucca P, Pezzani R, Martins N, Sharifi-Rad J. 2019. The therapeutic potential of naringenin: a review of clinical trials. Pharmaceuticals 12(1):11.
  • Santoro CM, Duchsherer NL, Grainger D. 2007. Antimicrobial efficacy and ocular cell toxicity from silver nanoparticles. Nanobiotechnology 3(2):55–65.
  • Shahbandeh M, Eghdami A, Moosazadeh Moghaddam M, Jalali Nadoushan M, Salimi A, Fasihi-Ramandi M, Mohammadi S, M, Mirzaei M, Mirnejad R. 2021. Conjugation of imipenem to silver nanoparticles for enhancement of its antibacterial activity against multidrug-resistant isolates of Pseudomonas aeruginosa. J Biosci. 46(1):1–19.
  • Song HM, Park GH, Eo HJ, Lee JW, Kim MK, Lee JR, Lee MH, Koo JS, Jeong JB. 2015. Anti-proliferative effect of naringenin through p38-dependent downregulation of cyclin D1 in human colorectal cancer cells. Biomol Ther (Seoul). 23(4):339–344.
  • Tripoli E, La Guardia M, Giammanco S, Di M, Giammanco M. 2007. Citrus flavonoids:molecular structure, biological activity and nutritional properties: a review. Food Chem. 104(2):466–479.
  • Yousuf S, Enoch IV. 2013. Binding interactions of naringenin and naringin with calf thymus DNA and the role of β-cyclodextrin in the binding. AAPS. Pharm. SciTech. 14(2):770–781.
  • Zhang L, Song L, Zhang P, Liu T, Zhou L, Yang G, Lin R, Zhang J. 2015. Solubilities of naringin and naringenin in different solvents and dissociation constants of naringenin. J Chem Eng Data. 60(3):932–940.
  • Zimet P, Valadez R, Raffaelli S, Estevez MB, Pardo H, Alborés S. 2021. Biogenic silver nanoparticles conjugated with nisin: improving the antimicrobial and antibiofilm properties of nanomaterials. Chemistry 3(4):1271–1285.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.